Abstract
LKB1 deficiency leads to the formation of cold tumor immune microenvironment (TME) and primary resistance to ICIs in lung adenocarcinoma. But specific molecular mechanisms are still incompletely understood. The hub role of LKB1 lies in the ability to control cell metabolism. Therefore, tackling vulnerabilities concerning immuno-metabolism probably is the breakthrough to reshape microenvironment and restore anti-tumor immunity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
